# A Study of Preoperative Radiation Therapy and Capecitabine in Locally Advanced Rectal Cancer

> **NCT00122291** · PHASE2 · UNKNOWN · sponsor: **Alberta Health services** · enrollment: 66 (estimated)

## Conditions studied

- Rectal Cancer
- Neoplasm Metastasis

## Interventions

- **DRUG:** Capecitabine
- **PROCEDURE:** Pelvic radiation

## Key facts

- **NCT ID:** NCT00122291
- **Lead sponsor:** Alberta Health services
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2002-01
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 66 (ESTIMATED)
- **Last updated:** 2012-01-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00122291

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00122291, "A Study of Preoperative Radiation Therapy and Capecitabine in Locally Advanced Rectal Cancer". Retrieved via AI Analytics 2026-08-18 from https://api.ai-analytics.org/clinical/NCT00122291. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*